Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 538,763 | 541,742 | 299,845 | 138,530 | 123,562 |
| Cost of Goods | 151,729 | 254,767 | 279,457 | 639 | 3,791 |
| Gross Profit | 387,034 | 286,975 | 20,388 | 137,891 | 119,771 |
| Operating Expenses | 389,233 | 371,607 | 1,068,201 | 67,129 | 77,418 |
| Operating Income | -1,470 | -83,865 | -1,047,356 | 71,401 | 43,144 |
| Other Income | 6,413 | 11,726 | -19,504 | 1,986 | 3,253 |
| Pre-tax Income | 4,943 | -72,139 | -1,066,860 | 73,387 | 46,397 |
| Income Tax | 4,116 | -30,941 | -76,297 | 27,887 | 17,631 |
| Net Income Continuous | 827 | -41,198 | -990,563 | 45,500 | 28,766 |
| Net Income | $827 | $-41,198 | $-990,563 | $45,500 | $28,766 |
| EPS Basic Total Ops | 0.00 | -0.12 | -5.66 | 0.29 | 0.18 |
| EPS Basic Continuous Ops | 0.00 | -0.12 | -5.66 | 0.29 | 0.19 |
| EPS Diluted Total Ops | 0.00 | -0.12 | -5.59 | 0.26 | 0.17 |
| EPS Diluted Continuous Ops | 0.00 | -0.12 | -5.56 | 0.25 | 0.16 |
| EBITDA(a) | $100,086 | $17,921 | $-996,008 | $75,258 | $46,147 |